RecruitingNot ApplicableNCT07022067

EVOLVING AZIMUTH IN MUSA CONTEXT

Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Enrollment

184 participants

Start Date

Oct 2, 2024

Study Type

INTERVENTIONAL

Conditions

Heart Failure Blood Pressure Weight Change Telemonitoring

Summary

Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a digital app designed to help people with chronic coronary syndrome (stable heart disease) better manage their condition between clinic visits, including tracking symptoms and supporting communication with their care team. **You may be eligible if...** - You have been diagnosed with chronic coronary syndrome (stable coronary artery disease) per cardiology guidelines - You are 18 or older - You were admitted to hospital or visited an emergency department due to your heart condition in the past year - You have a smartphone (Android or iOS) with Wi-Fi or mobile data at home **You may NOT be eligible if...** - You have a severe psychiatric disorder - You are unable to use smartphones or the provided equipment - You do not consent to participate Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.